Skip to main content

Anna Astriab-Fisher, Steven Paul

Anna Astriab-Fisher has been named vice president of assay development at GenTel BioSciences, the Madison, Wis.-based protein-array company said last week.

Prior to joining GenTel, Astriab-Fisher worked in the technology-development department of GlaxoSmithKline where she specialized in immunoassay protocols.

Sigma-Aldrich's board of directors elected Steven Paul to be a company director, Sigma said last week.
Paul currently is executive vice president for science and technology and president of the Lilly Research Laboratories of Eli Lilly.
Before working at Eli Lilly, Paul served as scientific director of the National Institutes of Health.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.